BP001110-PRO-089: Recombinant Human Sex determining region Y box 2 (SOX2) protein, Polyarginine-Tag
Source: E.coli-derived.
Purity: > 95.0% as determined by (a) Analysis by SEC-HPLC; (b) Analysis by SDS-PAGE.BP001214-PRO-679: Recombinant Human Annexin A1 (ANXA1) Protein
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.BP000421-HCV-223: Recombinant HCV NS5 Genotype-5
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.BP000421-HCV-222: Recombinant HCV NS5 Genotype-4
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-227: Recombinant HCV NS5 Genotype-1a
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000420-HCV-260: Recombinant HCV NS4 Mosaic Genotype-5
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity >95% by 10% PAGE.
Applications: ELISA, WB.BP000420-HCV-258: Recombinant HCV NS4 Mosaic Genotype-2
Source: E.coli-derived.
Purity >95% by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000420-HCV-257: Recombinant HCV NS4 Mosaic Genotype-1
Source: E.coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity >95% by 10% PAGE.BP000420-HCV-258: Recombinant HCV NS4 Mosaic Genotype-2
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity >95% by 10% PAGE.
Applications: ELISA and Western blots.BP000419-HCV-251: Recombinant HCV NS3 Genotype-3, (1356-1459 a.a.)
Source: E. coli-derived.
Purity>95% by 10% PAGE.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.